Daniel E. Greenleaf
2018
In 2018, Daniel E. Greenleaf earned a total compensation of $4.1M as President & Chief Executive Officer at BioScrip, a 72% increase compared to previous year.
Compensation breakdown
| Option Awards | $382,125 |
|---|---|
| Salary | $749,519 |
| Stock Awards | $2,979,665 |
| Total | $4,111,309 |
Greenleaf received $3M in stock awards, accounting for 72% of the total pay in 2018.
Greenleaf also received $382.1K in option awards and $749.5K in salary.
Rankings
In 2018, Daniel E. Greenleaf's compensation ranked 2,690th out of 14,244 executives tracked by ExecPay. In other words, Greenleaf earned more than 81.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,690 out of 14,244 | 81st |
Division Services | 556 out of 2,374 | 77th |
Major group Health Services | 42 out of 218 | 81st |
Industry group Home Health Care Services | 5 out of 23 | 78th |
Industry Home Health Care Services | 5 out of 23 | 78th |
Pay ratio
| Daniel E. Greenleaf's Pay | $4,111,309 |
|---|---|
| Median Employee's Pay | $50,916 |
| Pay Ratio | 81to 1 |
In 2018, the annual total compensation of Daniel E. Greenleaf was $4,111,309.
The annual total compensation of the median employee at BioScrip was $50,916.
The ratio of Daniel E. Greenleaf's pay to the pay of median employee was therefore 81 to one.
Source: SEC filing on April 30, 2019.
Greenleaf's colleagues
We found four more compensation records of executives who worked with Daniel E. Greenleaf at BioScrip in 2018.